Data: Flu-Season Enrollment, Trop2 Pathways & Academic Referral ROI
Seasonality and biomarkers are reshaping enrollment: flu-season and awareness-month uplifts, Trop2-driven oncology pathways, and academic referral ROI create predictable windows to convert patient interest into reliable trial participation.
Robert Maxwell
Oct 01, 2025
breast cancer trials
Trop2 targeted therapies
Sjogrens disease research
Psoriatic arthritis studies
